| Attributes | Values |
|---|
| rdf:type
| |
| Description
| - Cyclosporin A is a well-known calcineurin inhibitor that has been used for prophylactic immunosuppression after organ transplantation. The aim of this stud was to evaluate the eflicacy and safety of a new genetic cyclosporin formulation, Equoral (Teva Pharmaceuticals), in the treatment of de novo renal transplant recipients. Methods:Twenty cadaveric-donor renal transplant recipients between 23 abd 71 years of age at the tie of transplantation (mean age 52+-12,5 years) wete folkowed for 12 montis to determie if the gratts functioned and ion there were rejection attacks and side effects. In addition to cyclosporin, all patients received mycophenolate mofetil (CellCept) and Prednisone (Prednison). Results. Mean serum creatinine level decreased significantly after transplantation. in 6 of the 20 patients observed. 7 biopsies showed acute rejection episodes (35%) Over the 12-month post-transplant periodm,´, all patients showed stable graft function, with a mean serum creatinine level of 202.1 +- 130.9 um
- Cyclosporin A is a well-known calcineurin inhibitor that has been used for prophylactic immunosuppression after organ transplantation. The aim of this stud was to evaluate the eflicacy and safety of a new genetic cyclosporin formulation, Equoral (Teva Pharmaceuticals), in the treatment of de novo renal transplant recipients. Methods:Twenty cadaveric-donor renal transplant recipients between 23 abd 71 years of age at the tie of transplantation (mean age 52+-12,5 years) wete folkowed for 12 montis to determie if the gratts functioned and ion there were rejection attacks and side effects. In addition to cyclosporin, all patients received mycophenolate mofetil (CellCept) and Prednisone (Prednison). Results. Mean serum creatinine level decreased significantly after transplantation. in 6 of the 20 patients observed. 7 biopsies showed acute rejection episodes (35%) Over the 12-month post-transplant periodm,´, all patients showed stable graft function, with a mean serum creatinine level of 202.1 +- 130.9 um (en)
- Cyclosporin A is a well-known calcineurin inhibitor that has been used for prophylactic immunosuppression after organ transplantation. The aim of this stud was to evaluate the eflicacy and safety of a new genetic cyclosporin formulation, Equoral (Teva Pharmaceuticals), in the treatment of de novo renal transplant recipients. Methods:Twenty cadaveric-donor renal transplant recipients between 23 abd 71 years of age at the tie of transplantation (mean age 52+-12,5 years) wete folkowed for 12 montis to determie if the gratts functioned and ion there were rejection attacks and side effects. In addition to cyclosporin, all patients received mycophenolate mofetil (CellCept) and Prednisone (Prednison). Results. Mean serum creatinine level decreased significantly after transplantation. in 6 of the 20 patients observed. 7 biopsies showed acute rejection episodes (35%) Over the 12-month post-transplant periodm,´, all patients showed stable graft function, with a mean serum creatinine level of 202.1 +- 130.9 um (cs)
|
| Title
| - Efficacy of Equoral in Prophylactic Immunosuppression after De Novo Kidnex Transplantation
- Efficacy of Equoral in Prophylactic Immunosuppression after De Novo Kidnex Transplantation (en)
- Efficacy of Equoral in Prophylactic Immunosuppression after De Novo Kidnex Transplantation (cs)
|
| skos:prefLabel
| - Efficacy of Equoral in Prophylactic Immunosuppression after De Novo Kidnex Transplantation
- Efficacy of Equoral in Prophylactic Immunosuppression after De Novo Kidnex Transplantation (en)
- Efficacy of Equoral in Prophylactic Immunosuppression after De Novo Kidnex Transplantation (cs)
|
| skos:notation
| - RIV/61989592:15110/07:00004195!RIV08-MSM-15110___
|
| http://linked.open.../vavai/riv/strany
| |
| http://linked.open...avai/riv/aktivita
| |
| http://linked.open...avai/riv/aktivity
| |
| http://linked.open...iv/cisloPeriodika
| |
| http://linked.open...vai/riv/dodaniDat
| |
| http://linked.open...aciTvurceVysledku
| |
| http://linked.open.../riv/druhVysledku
| |
| http://linked.open...iv/duvernostUdaju
| |
| http://linked.open...titaPredkladatele
| |
| http://linked.open...dnocenehoVysledku
| |
| http://linked.open...ai/riv/idVysledku
| - RIV/61989592:15110/07:00004195
|
| http://linked.open...riv/jazykVysledku
| |
| http://linked.open.../riv/klicovaSlova
| - cyclosporin A; transplantation (en)
|
| http://linked.open.../riv/klicoveSlovo
| |
| http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
| http://linked.open...ontrolniKodProRIV
| |
| http://linked.open...i/riv/nazevZdroje
| |
| http://linked.open...in/vavai/riv/obor
| |
| http://linked.open...ichTvurcuVysledku
| |
| http://linked.open...cetTvurcuVysledku
| |
| http://linked.open...UplatneniVysledku
| |
| http://linked.open...v/svazekPeriodika
| |
| http://linked.open...iv/tvurceVysledku
| - Horák, Pavel
- Zadražil, Josef
- Kamarád, Vojtěch
- Bachleda, Petr
- Gibejová, Agáta
|
| issn
| |
| number of pages
| |
| http://localhost/t...ganizacniJednotka
| |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)